Sarepta Therapeutics所有资讯

Sarepta Therapeutics | 4：持股变动声明-高管 Rodino-Klapac Louise

11/20 20:02 (美东)

Sarepta Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Janus Henderson Group plc(4.6%)

11/14 09:46 (美东)

Sarepta Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Capital International Investors(6.7%)

11/13 10:33 (美东)

Sarepta Therapeutics | 4：持股变动声明-董事 Connelly Deirdre P

09/16 20:07 (美东)

Sarepta Therapeutics | 3：首次持股声明-董事 Connelly Deirdre P

09/16 20:02 (美东)

Sarepta Therapeutics | 4：持股变动声明-董事 BEHRENS M KATHLEEN

09/05 20:03 (美东)

Sarepta Therapeutics | 4：持股变动声明-高管 Estepan Ian Michael

09/03 20:02 (美东)

Sarepta Therapeutics | 4：持股变动声明-董事 Chambers Michael Andrew

08/20 08:03 (美东)

Sarepta Therapeutics | 4：持股变动声明-董事 BEHRENS M KATHLEEN

07/08 20:03 (美东)

Sarepta Therapeutics | 4：持股变动声明-高管 Brown Ryan Edward

06/25 20:05 (美东)

Sarepta Therapeutics | 4：持股变动声明-高管 Rodino-Klapac Louise

06/25 20:01 (美东)

Sarepta Therapeutics | 4：持股变动声明-高管 Murray Dallan

06/25 20:01 (美东)

Sarepta Therapeutics | 4：持股变动声明-高管 Estepan Ian Michael

06/25 20:01 (美东)

Sarepta Therapeutics | 4：持股变动声明-高管 Arif Bilal

06/25 20:01 (美东)

Sarepta Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-BlackRock, Inc.(10.7%)

06/07 13:33 (美东)

Sarepta Therapeutics | 4：持股变动声明-高管 Murray Dallan

05/06 20:10 (美东)

Sarepta Therapeutics | 3：首次持股声明-高管 Murray Dallan

05/06 20:05 (美东)

Sarepta Therapeutics | 4：持股变动声明-董事 Wigzell Hans Lennart Rudolf

03/11 20:03 (美东)

Sarepta Therapeutics | 4：持股变动声明-高管 Arif Bilal

03/11 20:03 (美东)

Sarepta Therapeutics | 4：持股变动声明-高管 Rodino-Klapac Louise

03/11 20:03 (美东)